269 related articles for article (PubMed ID: 16299031)
1. Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation.
Philippe D; Chakass D; Thuru X; Zerbib P; Tsicopoulos A; Geboes K; Bulois P; Breisse M; Vorng H; Gay J; Colombel JF; Desreumaux P; Chamaillard M
Gut; 2006 Jun; 55(6):815-23. PubMed ID: 16299031
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation.
Philippe D; Dubuquoy L; Groux H; Brun V; Chuoï-Mariot MT; Gaveriaux-Ruff C; Colombel JF; Kieffer BL; Desreumaux P
J Clin Invest; 2003 May; 111(9):1329-38. PubMed ID: 12727924
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effects of pancreatitis associated protein in inflammatory bowel disease.
Gironella M; Iovanna JL; Sans M; Gil F; Peñalva M; Closa D; Miquel R; Piqué JM; Panés J
Gut; 2005 Sep; 54(9):1244-53. PubMed ID: 15870231
[TBL] [Abstract][Full Text] [Related]
4. micro-Opioid receptor activation prevents acute hepatic inflammation and cell death.
Chakass D; Philippe D; Erdual E; Dharancy S; Malapel M; Dubuquoy C; Thuru X; Gay J; Gaveriaux-Ruff C; Dubus P; Mathurin P; Kieffer BL; Desreumaux P; Chamaillard M
Gut; 2007 Jul; 56(7):974-81. PubMed ID: 17299060
[TBL] [Abstract][Full Text] [Related]
5. Intestinal epithelial cells from inflammatory bowel disease patients preferentially stimulate CD4+ T cells to proliferate and secrete interferon-gamma.
Dotan I; Allez M; Nakazawa A; Brimnes J; Schulder-Katz M; Mayer L
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1630-40. PubMed ID: 17347451
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD45RB functionally distinguishes intestinal T lymphocytes in inflammatory bowel disease.
Ten Hove T; The Olle F; Berkhout M; Bruggeman JP; Vyth-Dreese FA; Slors JF; Van Deventer SJ; Te Velde AA
J Leukoc Biol; 2004 Jun; 75(6):1010-5. PubMed ID: 15020649
[TBL] [Abstract][Full Text] [Related]
7. Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease.
Monteleone G; Kumberova A; Croft NM; McKenzie C; Steer HW; MacDonald TT
J Clin Invest; 2001 Aug; 108(4):601-9. PubMed ID: 11518734
[TBL] [Abstract][Full Text] [Related]
8. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
9. Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells.
Bisping G; Lügering N; Lütke-Brintrup S; Pauels HG; Schürmann G; Domschke W; Kucharzik T
Clin Exp Immunol; 2001 Jan; 123(1):15-22. PubMed ID: 11167992
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of interleukin-12 and -17 in active inflammatory bowel disease.
Nielsen OH; Kirman I; Rüdiger N; Hendel J; Vainer B
Scand J Gastroenterol; 2003 Feb; 38(2):180-5. PubMed ID: 12678335
[TBL] [Abstract][Full Text] [Related]
11. Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production.
Liu Z; Colpaert S; D'Haens GR; Kasran A; de Boer M; Rutgeerts P; Geboes K; Ceuppens JL
J Immunol; 1999 Oct; 163(7):4049-57. PubMed ID: 10491009
[TBL] [Abstract][Full Text] [Related]
12. TL1A as a Potential Local Inducer of IL17A Expression in Colon Mucosa of Inflammatory Bowel Disease Patients.
Ślebioda TJ; Bojarska-Junak A; Stanisławowski M; Cyman M; Wierzbicki PM; Roliński J; Celiński K; Kmieć Z
Scand J Immunol; 2015 Oct; 82(4):352-60. PubMed ID: 26072972
[TBL] [Abstract][Full Text] [Related]
13. Persistent clonal expansions of peripheral blood CD4+ lymphocytes in chronic inflammatory bowel disease.
Probert CS; Chott A; Turner JR; Saubermann LJ; Stevens AC; Bodinaku K; Elson CO; Balk SP; Blumberg RS
J Immunol; 1996 Oct; 157(7):3183-91. PubMed ID: 8816432
[TBL] [Abstract][Full Text] [Related]
14. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
[TBL] [Abstract][Full Text] [Related]
15. Expression of NOX1, a superoxide-generating NADPH oxidase, in colon cancer and inflammatory bowel disease.
Szanto I; Rubbia-Brandt L; Kiss P; Steger K; Banfi B; Kovari E; Herrmann F; Hadengue A; Krause KH
J Pathol; 2005 Oct; 207(2):164-76. PubMed ID: 16086438
[TBL] [Abstract][Full Text] [Related]
16. A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3alpha, by gut epithelial cells.
Caruso R; Fina D; Peluso I; Stolfi C; Fantini MC; Gioia V; Caprioli F; Del Vecchio Blanco G; Paoluzi OA; Macdonald TT; Pallone F; Monteleone G
Gastroenterology; 2007 Jan; 132(1):166-75. PubMed ID: 17241869
[TBL] [Abstract][Full Text] [Related]
17. Expression of interleukin 1 beta and interleukin 1 beta converting enzyme by intestinal macrophages in health and inflammatory bowel disease.
McAlindon ME; Hawkey CJ; Mahida YR
Gut; 1998 Feb; 42(2):214-9. PubMed ID: 9536946
[TBL] [Abstract][Full Text] [Related]
18. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T
Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165
[TBL] [Abstract][Full Text] [Related]
19. Proteolytic cleavage and loss of function of biologic agents that neutralize tumor necrosis factor in the mucosa of patients with inflammatory bowel disease.
Biancheri P; Brezski RJ; Di Sabatino A; Greenplate AR; Soring KL; Corazza GR; Kok KB; Rovedatti L; Vossenkämper A; Ahmad N; Snoek SA; Vermeire S; Rutgeerts P; Jordan RE; MacDonald TT
Gastroenterology; 2015 Nov; 149(6):1564-1574.e3. PubMed ID: 26170138
[TBL] [Abstract][Full Text] [Related]
20. Lesional accumulation of CD163-expressing cells in the gut of patients with inflammatory bowel disease.
Franzè E; Caruso R; Stolfi C; Sarra M; Cupi ML; Caprioli F; Monteleone I; Zorzi F; De Nitto D; Colantoni A; Biancone L; Pallone F; Monteleone G
PLoS One; 2013; 8(7):e69839. PubMed ID: 23922818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
